In contrast, after the introduction of the first FRα-targeted fluorescence imaging probe to the intraoperative setting, which enabled the tumor-specific visualization of ovarian cancer metastases during surgery, folate-FITC (EC17) was evaluated in a larger EOC patient cohort [10,11]. This evidence concerns the gene FOLR1 and neoplasm.